Comparing three motor-sparing nerve blocks for pain after hip replacement
Official title: A Randomized, Double-Blinded, Controlled Trial Comparing the Analgesic Efficacy and Motor-Sparing Properties of the Pericapsular Nerve Group (PENG) Block, Suprainguinal Fascia Iliaca Compartment Block (S-FICB), and Lumbar Erector Spinae Plane Block (L-ESPB) in Patients Undergoing Hip Arthroplasty
Run by Poznan University of Medical Sciences · NCT07288983 · Data updated 2026-11-12
This trial will test whether the PENG block, suprainguinal FICB, or lumbar ESPB provides the best pain relief while preserving leg strength after hip arthroplasty in adults 65 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 100 Years |
| Sex | All |
| Enrollment | 93 (estimated) |
| Sponsor | Poznan University of Medical Sciences Academic / other |
| Locations | 1 site (Poznan) |
| Status | Recruiting |
| Started | February 6, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | March 4, 2026 |
| Trial ID | NCT07288983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 65 years or older scheduled for elective hip arthroplasty under spinal anesthesia who can give informed consent, reliably use a numeric pain scale, meet ASA II-III criteria, and are expected to remain hospitalized for at least 48 hours.
✕Probably not a fit
Patients with coagulopathy or therapeutic anticoagulation, local infection at the block site, allergy to local anesthetics, pre-existing lower-limb neurological deficits, severe spinal deformity, chronic opioid dependence, or inability to consent or report pain are unlikely to be eligible or to receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blinded, three-arm controlled study enrolls adults aged 65 and older undergoing elective hip arthroplasty under spinal anesthesia and randomizes them to receive a PENG block, suprainguinal FICB, or lumbar ESPB for postoperative analgesia. Investigators will compare postoperative pain scores at rest and during movement, opioid consumption, time to first rescue analgesia, quadriceps strength, incidence of nausea and vomiting, block-related adverse events, and early mobilization. Blocks are selected for their motor-sparing potential to facilitate early mobilization, and outcome data will be collected during at least 48 hours of postoperative hospitalization. The trial aims to determine which technique best balances effective analgesia with preserved motor function to improve early functional recovery after hip surgery.
Why it matters
Potential benefit: If successful, the trial could identify a nerve-block technique that reduces postoperative pain and opioid use while preserving quadriceps strength and enabling earlier, safer mobilization.
How similar studies have gone: Smaller randomized trials and observational studies indicate that PENG, suprainguinal FICB, and ESPB can reduce postoperative pain and opioid use, but direct head-to-head randomized comparisons of all three techniques in the same population are limited, so this comprehensive comparison is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 65 years or older scheduled to undergo elective hip arthroplasty under spinal anesthesia. * Ability to provide written informed consent. * Ability to understand and reliably use numerical pain assessment tools (NRS 0-10). * ASA physical status II-III. * Expected postoperative hospitalization of at least 48 hours to ensure complete data collection. Exclusion Criteria: * Inability to provide informed consent due to cognitive impairment, language barrier, or severe hearing/speech limitations. * Coagulopathy or therapeutic anticoagulation not meeting safety criteria for regional anesthesia. * Local infection at the planned block site. * Allergy, hypersensitivity, or contraindication to ropivacaine, local anesthetics, or study medications. * Pre-existing lower-limb neurological deficits (motor or sensory) affecting outcome assessments. * Severe spinal deformity or anatomical limitations preventing safe performance of regional blocks. * Chronic opioid use (defined as \>30 mg oral morphine equivalents daily for more than 2 weeks). * Severe renal failure (eGFR \<30 mL/min/1.73m²) or severe hepatic impairment. * Uncontrolled diabetes mellitus (fasting glucose \>300 mg/dL or HbA1c \>10%). * History of local anesthetic systemic toxicity (LAST). * Participation in another interventional clinical trial within the past 30 days. * Any condition deemed by investigators to interfere with protocol adherence, safety monitoring, or outcome reliability.
Where it's running
-
Poznan University of Medical Sciences
Poznan, Poland Recruiting
Study contacts
- Study coordinator: Malgorzata Reysner, MD PhD
- Email: mreysner@ump.edu.pl
- Phone: +48 61 873 83 03
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ceramic hip resurfacing vs total hip arthroplasty for hip OA
This trial tests whether ceramic hip resurfacing helps people with hip OA walk farther each day than a modern total hip replacement.
-
Dexmedetomidine during hip replacement to modulate nerves and inflammation
A randomized, placebo-controlled study tests whether intravenous dexmedetomidine given during spinal anesthesia with a PENG nerve block can help regulate the body's stress and inflammatory response and improve recovery after hip replacement.
-
Preoperative Fasting to Shape the Gut with Hip Replacement
This trial tests whether a 20-day preoperative fasting plan can lower inflammatory signals and broaden gut microbes in adults undergoing total hip arthroplasty.
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
-
Spinal anesthesia with intrathecal morphine vs PENG block (with or without dexamethasone) for hip replacement
In people aged 60 and older undergoing total hip arthroplasty, this study tests whether three anesthesia approaches provide better pain control and fewer side effects: spinal with intrathecal morphine, spinal with a PENG block, or spinal with a PENG block plus dexamethasone.
-
Intravenous dexamethasone for better pain control after hip replacement with a PENG block
This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.